OTC · GREH
Green Rain Energy Holdings Inc.
$0.01$0.00 (+1.68%)
Green Rain Energy Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.23% below the high.
Loading market information…
OTC · INLB · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Item 9 Labs Corp.’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of -$0.04. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Item 9 Labs Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2022 | May 16, 2022 | -$0.04-33.33% vs estimate | $6.64M-9.07% vs estimate |
|---|
| Q1 2022 | Feb 14, 2022 | -$0.040.0% vs estimate | $6.19M-15.26% vs estimate |
|---|
| Q1 2022 | Jan 18, 2022 | -$0.09-125.0% vs estimate | $6.09M-1.71% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (+1.68%)
Green Rain Energy Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.23% below the high.
$0.00$0.00 (0.0%)
Jack Nathan Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.00$0.00 (0.0%)
Love Hemp Group Plc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
South American Gold Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cannabis Global Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00$0.00 (0.0%)
Biome Grow Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Hero Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Transnational Cannabis Ltd.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
